Doxycycline vs Ipilimumab

Doxycycline vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Doxycycline and Ipilimumab.

Mechanism of Action

Doxycycline: Inhibits bacterial protein synthesis by binding 30S ribosomal subunit.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Doxycycline — 18-22 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Doxycycline — C22H24N2O8.

Molecular Weight: Doxycycline — 444.4350 g/mol.

Type: Doxycycline — Small molecule; Ipilimumab — Antibody.